William Blair & Company
SLXP

William Blair & Company’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

William Blair & Company’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,194
Closed -$379K – 2270
2015
Q1 		$379K Sell
2,194
-2,250
-51% -$330K ﹤0.01% 1815
2014
Q4 		$510K Sell
4,444
-244,774
-98% -$29.7M ﹤0.01% 1684
2014
Q3 		$38.9M Sell
249,218
-669,689
-73% -$97.1M 0.07% 372
2014
Q2 		$113M Sell
918,907
-97,701
-10% -$10.8M 0.19% 163
2014
Q1 		$105M Buy
1,016,608
+185,281
+22% +$19M 0.17% 179
2013
Q4 		$74.8M Buy
831,327
+826,713
+17,917% +$65.9M 0.12% 245
2013
Q3 		$308K Hold
4,614
– – ﹤0.01% 1715
2013
Q2 		$305K Buy
+4,614
New +$264K ﹤0.01% 1658

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

William Blair & Company's SLXP Position: Q2 2015 in Review

William Blair & Company sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 2,194 shares — an estimated $379K sold.

William Blair & Company first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $113M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • William Blair & Company reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • William Blair & Company sold 2,194 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $379K.
  • William Blair & Company first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • William Blair & Company's SALIX PHARMACEUTICALS LTD DEL position peaked at $113M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on William Blair & Company's 13F filing for Q2 2015, filed 3 Aug 2015.